Scorpius Holdings Partners with KaloCyte to Enhance ErythroMer Manufacturing
Scorpius Holdings, Inc, an integrated contract development and manufacturing organization (“CDMO”), today announced its collaboration with KaloCyte, a pioneering pre-clinical company in the field of therapeutic innovation. Under this...